Providing Computational Insights into Cardiac Xenotransplantation

XENOSIM aims to advance cardiac xenotransplantation by developing high-resolution simulations to understand porcine heart compatibility and improve surgical outcomes.

Subsidie
€ 1.999.410
2024

Projectdetails

Introduction

We are at the dawn of a new age in medicine, marked by the first pig-to-human heart transplant. Xenotransplantation has long been a dream for clinicians and now, due to rapid progress in gene editing, is becoming a reality.

Challenges in Xenotransplantation

To overcome immediate rejection, barriers of immunity and infection have to be addressed. However, achieving long-term success requires a deep understanding of the physiological and mechanical challenges introduced by the anatomically dissimilar xenotransplants.

Project Goals

XENOSIM aims to address these challenges by providing fundamental clinical insights into the nascent field of cardiac xenotransplantation through the development and application of novel high-resolution, higher-order, multiphysics simulation methods.

Current Limitations

Tremendous progress has been made in biomedical imaging; nonetheless, a multitude of physical phenomena relevant to xenotransplantation are not available for experimental observation. In silico studies are uniquely placed to provide insights into the haemodynamic disruption caused by replacing a human heart with an anatomically dissimilar one.

Target Outcomes

XENOSIM is targeting the establishment of the first family of porcine cardiac xenotransplant models that can provide clinically significant insights into:

  1. The haemodynamic compatibility of porcine donor hearts
  2. The impact of surgical approach
  3. The consequence of pathologies

Methodological Innovations

To provide these novel insights requires new coupled simulation approaches. Accordingly, the second goal of XENOSIM is to create a new class of monolithic finite volume fluid-electro-solid interaction methods, which can provide predictions in clinically relevant timescales through the exploitation of hybrid CPU-GPU systems.

Broader Impact

XENOSIM will establish the new field of computational cardiac xenotransplantation. Furthermore, the novel numerical methods established by XENOSIM are expected to impact a broad range of fields well beyond the project end.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.410
Totale projectbegroting€ 1.999.410

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINpenvoerder

Land(en)

Ireland

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Using CARDIac simulations to run in-silicO clinical TRIALS

This project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials.

€ 1.499.423
ERC STG

Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs

G-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease.

€ 1.497.351
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

€ 4.475.946
ERC STG

Surgical optogenetic bioprinting of engineered cardiac muscle

LIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart.

€ 1.499.705